Target intelligence / Profile preview

Premature Stop Codon Readthrough (None)

Target
None
Molecular classification
Other
01

Overview

Premature stop codon readthrough refers to the process by which the ribosome bypasses a premature termination codon (PTC) during translation, allowing for continued protein synthesis and potentially restoring full-length, functional protein in cases where a nonsense mutation would otherwise truncate it. This phenomenon can occur naturally at low frequencies or be induced pharmacologically or genetically as a therapeutic strategy for genetic diseases caused by nonsense mutations.

02

Mechanism of action

Promotes near-cognate tRNA binding at premature stop codons, allowing translation to continue.

03

Biological functions

Translation elongationTranslation terminationProtein synthesis
04

Disease associations

Genetic diseases caused by nonsense mutations
05

Safety considerations

Off-target effects on normal termination eventsGlobal suppression of proper translational termination
06

Interacting drugs

Gentamicin

1 more in the full profile.

Beyond the preview

Go deeper on Premature Stop Codon Readthrough (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Premature Stop Codon Readthrough (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call